Latest Novo Holdings A/S Stock Portfolio
Novo Holdings A/S Performance:
2025 Q4: 6.85%YTD: 16.51%2024: -6.41%
Performance for 2025 Q4 is 6.85%, and YTD is 16.51%, and 2024 is -6.41%.
About Novo Holdings A/S and 13F Hedge Fund Stock Holdings
On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, NOVO HOLDINGS A/S reported an equity portfolio of $1.3 Billions as of 31 Dec, 2025.
The top stock holdings of NOVO HOLDINGS A/S are , EWTX, ASML. The fund has invested 12.5% of it's portfolio in BROOKFIELD CORP and 10.3% of portfolio in EDGEWISE THERAPEUTICS INC.
The fund managers got completely rid off VANGUARD INDEX FDS (VB), MERUS N V (MRUS) and RECURSION PHARMACEUTICALS IN (RXRX) stocks. They significantly reduced their stock positions in ZENAS BIOPHARMA INC, ASML HOLDING N V (ASML) and VALNEVA SE (VALN). NOVO HOLDINGS A/S opened new stock positions in MAPLIGHT THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to 4D MOLECULAR THERAPEUTICS IN (FDMT) and BROOKFIELD CORP.
The top stock holdings of NOVO HOLDINGS A/S are , EWTX, ASML. The fund has invested 12.5% of it's portfolio in BROOKFIELD CORP and 10.3% of portfolio in EDGEWISE THERAPEUTICS INC.
The fund managers got completely rid off VANGUARD INDEX FDS (VB), MERUS N V (MRUS) and RECURSION PHARMACEUTICALS IN (RXRX) stocks. They significantly reduced their stock positions in ZENAS BIOPHARMA INC, ASML HOLDING N V (ASML) and VALNEVA SE (VALN). NOVO HOLDINGS A/S opened new stock positions in MAPLIGHT THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to 4D MOLECULAR THERAPEUTICS IN (FDMT) and BROOKFIELD CORP.
Novo Holdings A/S Annual Return Estimates Vs S&P 500
Our best estimate is that NOVO HOLDINGS A/S made a return of 6.85% in the last quarter. In trailing 12 months, it's portfolio return was 16.51%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| maplight therapeutics inc | 64,755,500 |
New stocks bought by Novo Holdings A/S
Additions
| Ticker | % Inc. |
|---|---|
| 4d molecular therapeutics in | 82.54 |
| brookfield corp | 50.00 |
| apogee therapeutics inc | 14.00 |
| enliven therapeutics inc | 3.77 |
Additions to existing portfolio by Novo Holdings A/S
Reductions
| Ticker | % Reduced |
|---|---|
| zenas biopharma inc | -27.5 |
| asml holding n v | -21.87 |
| valneva se | -1.71 |
Novo Holdings A/S reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| recursion pharmaceuticals in | -38,697,600 |
| vanguard index fds | -340,821,000 |
| merus n v | -70,612,500 |
| galecto inc | -322,074 |
Novo Holdings A/S got rid off the above stocks
Sector Distribution
NOVO HOLDINGS A/S has about 49.5% of it's holdings in Others sector.
- Others
- Healthcare
- Technology
| Sector | % |
|---|---|
| Others | 49.5 |
| Healthcare | 43.5 |
| Technology | 7 |
Market Cap. Distribution
NOVO HOLDINGS A/S has about 12.5% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- LARGE-CAP
- SMALL-CAP
| Category | % |
|---|---|
| UNALLOCATED | 49.5 |
| MID-CAP | 33 |
| LARGE-CAP | 12.5 |
| SMALL-CAP | 4.8 |
Stocks belong to which Index?
About 47.3% of the stocks held by NOVO HOLDINGS A/S either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
- S&P 500
| Index | % |
|---|---|
| Others | 52.7 |
| RUSSELL 2000 | 40.5 |
| S&P 500 | 6.8 |
Novo Holdings A/S Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Novo Holdings A/S
NOVO HOLDINGS A/S has 24 stocks in it's portfolio. About 71.3% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. EWTX was the most profitable stock for NOVO HOLDINGS A/S last quarter.
Last Reported on: 17 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ASML | asml holding n v | 9.47 | 113,946 | 121,906,000 | reduced | -21.87 | ||
| BABA | alibaba group hldg ltd | 2.93 | 257,327 | 37,719,000 | unchanged | 0.00 | ||
| BMRN | biomarin pharmaceutical inc | 3.05 | 660,000 | 39,223,800 | unchanged | 0.00 | ||
| CLDX | celldex therapeutics inc new | 2.53 | 1,200,000 | 32,592,000 | unchanged | 0.00 | ||
| CRM | salesforce inc | 6.79 | 330,187 | 87,469,800 | unchanged | 0.00 | ||
| CRNX | crinetics pharmaceuticals in | 5.87 | 1,625,000 | 75,643,800 | unchanged | 0.00 | ||
| EWTX | edgewise therapeutics inc | 10.31 | 5,350,000 | 132,760,000 | unchanged | 0.00 | ||
| FDMT | 4d molecular therapeutics in | 2.13 | 3,650,740 | 27,380,500 | added | 82.54 | ||
| GLTO | galecto inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INSM | insmed inc | 2.70 | 200,000 | 34,808,000 | unchanged | 0.00 | ||
| IOBT | io biotech inc | 0.12 | 2,512,450 | 1,529,830 | unchanged | 0.00 | ||
| MIRM | mirum pharmaceuticals inc | 7.75 | 1,264,030 | 99,845,600 | unchanged | 0.00 | ||
| MQ | marqeta inc | 0.16 | 441,558 | 2,097,400 | unchanged | 0.00 | ||
| MRUS | merus n v | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PCVX | vaxcyte inc | 3.28 | 916,160 | 42,271,600 | unchanged | 0.00 | ||
| PHVS | pharvaris n v | 3.77 | 1,750,000 | 48,562,500 | unchanged | 0.00 | ||
| RXRX | recursion pharmaceuticals in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| VALN | valneva se | 1.58 | 2,305,000 | 20,330,100 | reduced | -1.71 | ||
| VB | vanguard index fds | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| VRDN | viridian therapeutics inc | 5.75 | 2,380,000 | 74,065,600 | unchanged | 0.00 | ||